Agonist-Specific Coupling of Growth Hormone Secretagogue Receptor Type 1a to Different Intracellular Signaling Systems: Role of Adenosine

Neuroendocrinology

Volumn 79, Issue 1, 2004, Pages 13-25

  Carreira, Marcos C ^a   Camiña, Jesus P ^a   Smith, Roy G ^b   Casanueva, Felipe F ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Adenosine; Calcium; cAMP; Ghrelin; Growth hormone secretagogue receptors; Inositol triphosphate; Protein kinases

Indexed keywords

2 AMINOETHOXYDIPHENYLBORANE; 2-AMINOETHOXYDIPHENYL BORATE; ADENOSINE; ADENYLATE CYCLASE; BORON DERIVATIVE; CALCIUM; CHOLERA TOXIN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; ENZYME INHIBITOR; G PROTEIN COUPLED RECEPTOR; GHRELIN; GROWTH HORMONE SECRETAGOGUE RECEPTOR; HEAVY METAL; IMMUNOLOGICAL ADJUVANT; INOSITOL 1,4,5 TRISPHOSPHATE; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; INOSITOL PHOSPHATE; IODINE; LYSOPHOSPHATIDIC ACID; N (2 PHENYLCYCLOPENTYL)AZACYCLOTRIDECAN 2 IMINE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PEPTIDE HORMONE; PERTUSSIS TOXIN; PHOSPHOLIPASE C; SUBSTANCE P [1 DEXTRO ARGININE 5 DEXTRO PHENYLALANINE 7,9 DEXTRO TRYPTOPHAN 11 LEUCINE]; THAPSIGARGIN; VASODILATOR AGENT;

ANALYSIS OF VARIANCE; ARTICLE; CALCIUM METABOLISM; CALCIUM MOBILIZATION; CELL LINE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; DRUG INTERACTION; DRUG POTENTIATION; DRUG RECEPTOR BINDING; EMBRYO; EXTRACELLULAR SPACE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; KIDNEY; METABOLISM; METHODOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RADIOASSAY; REGULATORY MECHANISM; SECOND MESSENGER; SIGNAL TRANSDUCTION;

ADENOSINE; ADJUVANTS, IMMUNOLOGIC; ANALYSIS OF VARIANCE; BORON COMPOUNDS; CALCIUM; CELL LINE; CHOLERA TOXIN; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EMBRYO; ENZYME INHIBITORS; EXTRACELLULAR SPACE; HUMANS; INOSITOL PHOSPHATES; IODINE ISOTOPES; KIDNEY; METALS, HEAVY; PEPTIDE HORMONES; PERTUSSIS TOXIN; PHOSPHOLIPASE C; RADIOLIGAND ASSAY; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; THAPSIGARGIN; TRANSFECTION; VASODILATOR AGENTS;

EID: 0442293404     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000076042     Document Type: Article

References (41)

1. Smith RG, Van der Ploeg LH, Howard AD, Feighner SD, Cheng K, Hickey GJ, Wyvratt MJ Jr, Fisher MH, Nargund RP, Patchett AA: Peptidomimetic regulation of growth hormone secretion. Endocr Rev 1997;18:621-645.
2. Casanueva FF, Dieguez C: Growth hormone secretagogues: Physiological role and clinical utility. Trends Endocrinol Metab 1999;10:30-38.
3. Pong SS, Chaung LY, Dean DC, Nargund RP, Patchett AA, Smith RG: Identification of a new G-protein-linked receptor for growth hormone secretagogues. Mol Endocrinol 1996;10:57-61.
4. Howard AD, Feighner SD, Cully DF, Arena JP, Liberator PA, Rosenblum CI, Hamelin M, Hreniuk DL, Palyha OC, Anderson J, Paress PS, Diaz C, Chou M, Liu KK, McKee KK, Pong SS, Chaung LY, Elbrecht A, Dashkevicz M, Heavens R, Rigby M, Sirinathsinghji DJ, Dean DC, Melillo DG, Van der Ploeg LH, et al: A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 1996;273:974-977.
5. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K: Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999;402:656-660.
6. Muccioli G, Tschöp M, Papotti M, Deghenghi R, Heiman M, Ghigo E: Neuroendocrine and peripheral activities of ghrelin: Implications in metabolism and obesity. Eur J Pharmacol 2002;440:235-254.
7. Casanueva FF, Dieguez C: Ghrelin: The link connecting growth with metabolism and energy homeostasis. Rev Endocrinol Metab Disord 2002;3:325-338.
8. Yokote R, Sato M, Matsubara S, Ohye H, Niimi M, Murao K, Takahara J: Molecular cloning and gene expression of growth hormone-releasing peptide receptors in rat tissues. Peptides 1998;19:15-20.
9. Shintani M, Ogawa Y, Ebihara K, Aizawa-Abe M, Miyanaga F, Takaya K, Hayashi T, Inoue G, Hosoda K, Kojima M, Kangawa K, Nakao K: Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes 2001;50:227-232.
10. Bluet-Pajot MT, Tolle V, Zizzari P, Robert C, Hammond C, Mitchell V, Beavillain JC, Viollet C, Epelbaum J, Kordon C: Growth hormone secretagogues and hypothalamic networks. Endocrine 2001;14:1-8.
11. Papotti M, Ghe C, Cassoni P, Catapano F, Deghenghi R, Ghigo E, Muccioli G: Growth hormone secretagogue binding sites in peripheral human tissues. J Clin Endocrinol Metab 2000;85:3803-3807.
12. Gnanapavan S, Kola B, Bustin SA, Morris DG, McGee P, Fairclough P, Bhattacharya S, Carpenter R, Grossman AB, Korbonits M: The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab 2002;87:2988-2991.
13. Tena-Sempere M, Barreiro ML, Gonzalez LC, Gaytan F, Zhang FP, Caminos JE, Pinilla L, Casanueva FF, Dieguez C, Aguilar E: Novel expression and functional role of ghrelin in rat testis. Endocrinology 2002;143:717-725.
14. Gaytan F, Barreiro ML, Chopin LK, Herinton AC, Morales C, Pinilla L, Casanueva FF, Aguilar E, Dieguez C, Tena-Sempere M: Immunolocalization of ghrelin and its functional receptor, the type 1a GH-secretagogue receptor, in the cyclic human ovary. J Clin Endocrinol Metab 2003;88:879-887.
15. Jeffery PL, Herington AC, Chopin LK: Expression and action of the growth hormone releasing peptide ghrelin and its receptor in prostate cancer cell lines. J Endocrinol 2002;172:R7-R11.
16. Feighner SD, Howard AD, Prendergast K, Palyha OC, Hreniuk DL, Nargund R, Underwood D, Tata JR, Dean DC, Tan CP, McKee KK, Woods JW, Patchett AA, Smith RG, Van der Ploeg LH: Structural requirements for the activation of the human growth hormone secretagogue receptor by peptide and nonpeptide secretagogues. Mol Endocrinol 1998;12:137-145.
17. Smith RG, Griffin PR, Xu Y, Smith AG, Liu K, Calacay J, Feighner SD, Pong C, Leong D, Pomes A, Cheng K, Van der Ploeg LH, Howard AD, Schaeffer J, Leonard RJ: Adenosine: A partial agonist of the growth hormone secretagogue receptor. Biochem Biophys Res Commun 2000;276:1306-1313.
18. Tullin S, Hansen BS, Ankersen M, Moller J, Von Cappelen KA, Thim L: Adenosine is an agonist of the growth hormone secretagogue receptor. Endocrinology 2000;141:3397-3402.
19. 2+ mobilization triggered by a lipid factor isolated from vitreous body. J Biol Chem 1999;274:28134-28141.
20. Antoni FA: Molecular diversity of cyclic AMP signalling. Front Neuroendocrinol 2000;21:103-132.
21. Grupp G, Grupp IL, Johnson CL, Matlib MA, Rouslin W, Schwartz A, Wallick ET, Wang T, Wisler P: Effects of RMI 12330A, a new inhibitor of adenylate cyclase on myocardial function and subcellular activity. Br J Pharmacol 1980;70:429-442.
22. Davies SP, Reddy H, Caivano M, Cohen P: Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 2000;351:95-105.
23. 2+ oscillations in HEK-293 cells. J Biol Chem 1995;270:2 4108-4115.
24. Haug LS, Jensen V, Hvalby O, Walaas SI, Ostvold AC: Phosphorylation of the inositol 1,4,5-trisphosphate receptor by cyclic nucleotide-dependent kinases in vitro and in rat cerebellar slices in situ. J Biol Chem. 1999;274:7467-7473.
25. 2+ signaling. J Biol Chem 2002;277:1340-1348.
26. DeSouza N, Reiken S, Ondrias K, Yang YM, Matkovich S, Marks AR: Protein kinase A and two phosphatases are components of the inositol 1,4, 5-trisphosphate receptor macromolecular signaling complex. J Biol Chem 2002;277:39397-39400.
27. Marx SO, Reiken S, Hisamatsu Y, Jayaraman T, Burkhoff D, Rosemblit N, Marks AR: PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): Defective regulation in failing hearts. Cell 2000;101:365-376.
28. 2+ release. J Biochem (Tokyo) 1997;122:498-505.
29. Putney JW Jr, Broad LM, Braun F-J, Lievremont J-P, Bird GSJ: Mechanisms of capacitative calcium entry. J Cell Sci 2001;114:2223-2229.
30. 2+ stores: Relationships revealed by image analysis of individual human fibroblasts. J Biol Chem 1992;267:108-118.
31. i oscillations in HEK293 cells. J Biol Chem 2001;276:5613-5621.
32. 2+ current in human prostate cancer LNCaP cells: Involvement in apoptosis. J Physiol 2000;527:71-83.
33. 2+ entry mediated by store depletion, S-nitrosylation, and TRP3 channels: Comparison of coupling and function. J Biol Chem 2000;275:28562-28568.
34. 2+ channels in liver cells, and acts through a mechanism which does not involve inositol trisphosphate receptors. Biochem J 2001;354:285-290.
35. Cooper J, Hill SJ, Alexander SP: An endogenous A2B adenosine receptor coupled to cyclic AMP generation in human embryonic kidney (HEK 293) cells. Br J Pharmacol 1997;122:546-550.
36. Mirabet M, Mallol J, Lluis C, Franco R: Calcium mobilization in Jurkat cells via A2b adenosine receptors. Br J Pharmacol 1997;122:1075-1082.
37. Gao Z, Chen T, Weber MJ, Linden J: A2B adenosine and P2Y2 receptors stimulate mitogen-activated protein kinase in human embryonic kidney-293 cells: Cross-talk between cyclic AMP and protein kinase c pathways. J Biol Chem 1999;274:5972-5980.
38. Linden J, Thai T, Figler H, Jin X, Robeva AS: Characterization of human A(2B) adenosine receptors: Radioligand binding, western blotting, and coupling to G(q) in human embryonic kidney 293 cells and HMC-1 mast cells. Mol Pharmacol 1999;56:705-713.
39. Abdel-Latif AA: Cross talk between cyclic nucleotides and polyphosphoinositide hydrolysis, protein kinases, and contraction in smooth muscle. Exp Biol Med (Maywood) 2001;226:153-163.
40. Camiña JP, Carreira MC, El Messari S, Llorens-Cortes C, Smith RG, Casanueva FF: Desensitization and endocytosis mechanisms of ghrelin-activated growth hormone secretagogue receptor 1a. Endocrinology 2003 Oct 23 (Epub ahead of print).
41. Ferguson SS: Evolving concepts in G protein-coupled receptor endocytosis: The role in receptor desensitization and signaling. Pharmacol Rev 2001;53:1-24.